Nonsense mutation in HLA-B*40: 02 in a case with acquired aplastic anaemia: A possible origin of clonal escape from autoimmune insult

British Journal of Haematology

Volumn 162, Issue 5, 2013, Pages 706-707

  Osumi, Tomoo ^a   Miharu, Masashi ^a   Saji, Hiroh ^b   Kusunoki, Yasushi ^b   Kojima, Hiroto ^b   Nakamura, Junko ^c   Shimada, Hiroyuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^c SUWA RED CROSS HOSPITAL   (Japan)

Author keywords

Aplastic anaemia; Autoimmune; Clonal escape; Human leucocyte antigen; Nonsense mutation

Indexed keywords

HLA B ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

APLASTIC ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; CODON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MOSAICISM; NONSENSE MUTATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RETREATMENT; THROMBOCYTOPENIA;

APLASTIC ANAEMIA; AUTOIMMUNE; CLONAL ESCAPE; HUMAN LEUCOCYTE ANTIGEN; NONSENSE MUTATION;

ANEMIA, APLASTIC; AUTOIMMUNE DISEASES; CHILD, PRESCHOOL; CODON, NONSENSE; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-B40 ANTIGEN; HUMANS; PEDIGREE;

EID: 84881662778     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12395     Document Type: Letter

References (5)

1. Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A. (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood, 95, 1931-1934.
2. Katagiri, T., Sato-Otsubo, A., Kashiwase, K., Morishima, S., Sato, Y., Mori, Y., Kato, M., Sanada, M., Morishima, Y., Hosokawa, K., Sasaki, Y., Ohtake, S., Ogawa, S. & Nakao, S. (2011) Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood, 118, 6601-6609.
3. Kojima, S., Hibi, S., Kosaka, Y., Yamamoto, M., Tsuchida, M., Mugishima, H., Sugita, K., Yabe, H., Ohara, A. & Tsukimoto, I. (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood, 96, 2049-2054.
4. Risitano, A.M., Maciejewski, J.P., Green, S., Plasilova, M., Zeng, W. & Young, N.S. (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. The Lancet, 364, 355-364.
5. Young, N.S. & Maciejewski, J. (1997) The pathophysiology of acquired aplastic anemia. The New England Journal of Medicine, 336, 1365-1372.